Showing results (101-110 of 1,291) with videos related to

Sort By:
Pageof 130
Veterinary and Comparative Oncology|August 9, 2018
In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancersSita S Withers, Daniel York, Eric Johnson, et al.
Veterinary and Comparative Oncology|May 4, 2017
High COX-2 expression in canine mast cell tumours is associated with proliferation, angiogenesis and decreased overall survivalH Gregório, T Raposo, F L Queiroga, et al.
Veterinary and Comparative Oncology|March 17, 2010
Feline intestinal sclerosing mast cell tumour: 50 cases (1997-2008)C H C Halsey, B E Powers, D A Kamstock
Veterinary and Comparative Oncology|September 1, 2016
A complication probability planning study to predict the safety of a new protocol for intracranial tumour radiotherapy in dogsC Rohrer Bley, V Meier, P Schwarz, et al.
Veterinary and Comparative Oncology|May 18, 2019
Surgical decompression, with or without adjunctive therapy, for palliative treatment of primary vertebral osteosarcoma in dogsAlexandra Dixon, Annie Chen, John H Rossmeisl, et al.
Veterinary and Comparative Oncology|May 18, 2019
Developing and testing prognostic bio-scoring systems for canine mammary gland carcinomasKarin U Sorenmo, Amy C Durham, Veronica Kristiansen, et al.
Veterinary and Comparative Oncology|May 10, 2019
Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011-2018Felicia H Lew, Bobbi McQuown, Juan Borrego, et al.
Veterinary and Comparative Oncology|May 10, 2019
Dasatinib inhibition of cSRC prevents the migration and metastasis of canine mammary cancer cells with enhanced Wnt and HER signallingElpetra P M Timmermans-Sprang, Helena M Mestemaker, Renske R Steenlage, et al.
Veterinary and Comparative Oncology|March 12, 2022
mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disordersMiyuki Hirabayashi, James K Chambers, Akiyoshi Tani, et al.
Pageof 130